Evidence map›Paper›PMID 19744582›Full record

ArticleBone2010

Thrombospondin-2 regulates matrix mineralization in MC3T3-E1 pre-osteoblasts.

Andrea I Alford, Shawn P Terkhorn, Anita B Reddy, Kurt D Hankenson

Abstract read
In one paragraph

Article in Bone, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Loss ofAmerican journal of physiology. Endocrinology and metabolism · 2019
    Article
  8. Cartilage oligomeric matrix protein: COMPopathies and beyond.Matrix biology : journal of the International Society for Matrix Biology · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Thrombospondin-2 and extracellular matrix assembly.Biochimica et biophysica acta · 2014
    Review
  16. Article
  17. Article
  18. Thrombospondins and synaptogenesis.Neural regeneration research · 2012
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Andrea I AlfordUniversity of Michigan School of Medicine, Department of Orthopaedic Surgery, Biological Sciences Research Building, Ann Arbor, MI 48109, USA. aialford@umich.edu
Shawn P Terkhorn
Anita B Reddy
Kurt D Hankenson
University of Michigan–Ann Arbor · USUniversity of Pennsylvania · US

Funding

Matricellular Proteins and Mesenchymal Stem CellsR01AR049682 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI HANKENSON, KURT DAVID · 2002 to 2006
$1.2M
NIAMS NIH HHS R01 AR049682
6 · The paper itself

Abstract

The matricellular protein thrombospondin-2 (TSP2) has context-dependent effects on osteoblast lineage proliferation and differentiation. Mice lacking TSP2 display increased endocortical bone thickness, which is associated with increased marrow stromal cell (MSC) number and in vitro proliferation. TSP2-null MSC also exhibit delayed osteoblastogenesis and enhanced adipogenesis compared to cells harvested from wild type mice. The goal of the present work was to more precisely characterize the contribution that TSP2 makes to the maturation of osteoblast-derived extracellular matrix (ECM) using a highly characterized pre-osteoblast cell line. Specifically, we asked whether TSP2 influences mineralization indirectly through its known effects on proliferation, or whether TSP2 directly promotes osteoblast differentiation. To pursue these questions, we used RNA-interference (RNAi) to inhibit TSP2 gene expression in MC3T3-E1 pre-osteoblasts. Introduction of siRNA oligonucleotides resulted in reduced TSP2 mRNA expression as early as 24 h post-transfection, and TSP2 mRNA levels remained low for 10 days. Similarly, TSP2 protein levels in both conditioned medium and the cell-matrix layer were reduced at 24 h post-transfection and remained reduced for 7 days. At day 21, mineralization was significantly reduced in cells transfected with TSP2 siRNA when compared to cells treated with scrambled siRNA. This decrease in mineralization occurred without a concomitant change in cell number. Twenty-four hours after transfection, runx2 gene expression was transiently enhanced in TSP2 siRNA-treated cultures. Between 6 and 14 days post-transfection, runx2, osterix, alkaline phosphatase, type I collagen, osteocalcin and bone sialoprotein all displayed moderate increases in gene expression with TSP2 RNAi. As well, soluble osteocalcin levels were markedly higher in the conditioned medium of cells treated with TSP2 siRNA than in control siRNA-treated cells. Increased soluble osteocalcin occurred without a concomitant change in the levels of osteocalcin in the cell-ECM layer. TSP2 reduction also elicited a transient change in the distribution of collagen between the acid soluble cell-ECM protein fraction and the insoluble matrix. Together, our data suggest that TSP2 may promote mineralization, by facilitating proper organization of the osteoblast-derived ECM.

Indexed as

3T3 CellsAnimalsBiomarkersCalcification, PhysiologicCell CountCell DifferentiationCore Binding Factor Alpha 1 SubunitExtracellular MatrixGene Expression RegulationMiceOrgan SpecificityOsteoblastsRNA InterferenceRNA, MessengerSp7 Transcription FactorThrombospondin 2BiomarkersCore Binding Factor Alpha 1 SubunitRNA, MessengerSp7 protein, mouseSp7 Transcription FactorThrombospondin 2ThrombospondinsTranscription Factors

Identifiers

PMID19744582
PMCPMC2818128
OpenAlexW2131577941

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.